CDEK
← All organizations
Avedro, Inc.

Avedro, Inc.

For profitWebsite ↗

Also known as: Avedro, Inc. | AVEDRO INC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Jan 1, 2009

First marketed drug

Apr 15, 2016

Last known activity

Mar 30, 2018

Acquired by Glaukos Corporation on Aug 7, 2019

Timeline

2000s

  1. Jan 1, 2009

    Avedro, Inc.— Founded

2010s

  1. Apr 15, 2016

    riboflavin— NDA Secondary Org

  2. Aug 7, 2019

    Glaukos Corporation— Acquired By

Drugs by trial phase (2 distinct, 9 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 3 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (14)

Details

Founded
Cambridge, Massachusetts, US Jan 1, 2009
Last known activity
Mar 30, 2018